Smith & Nephew plc (LON:SN) had its price objective cut by investment analysts at J P Morgan Chase & Co from GBX 1,382 ($18.18) to GBX 1,369 ($18.01) in a research report issued on Monday. The firm presently has a “neutral” rating on the stock. J P Morgan Chase & Co’s price target suggests a potential upside of 3.63% from the stock’s current price.

A number of other research analysts have also recently issued reports on the company. Jefferies Group LLC reissued a “buy” rating and set a GBX 1,515 ($19.93) price objective on shares of Smith & Nephew plc in a report on Monday, November 6th. Berenberg Bank reissued a “hold” rating and set a GBX 1,340 ($17.62) price objective on shares of Smith & Nephew plc in a report on Friday, November 3rd. Deutsche Bank AG lifted their price objective on Smith & Nephew plc from GBX 1,200 ($15.78) to GBX 1,315 ($17.30) and gave the company a “hold” rating in a report on Monday, October 23rd. Citigroup Inc. reissued a “sell” rating and set a GBX 1,160 ($15.26) price objective on shares of Smith & Nephew plc in a report on Thursday, October 12th. Finally, Goldman Sachs Group, Inc. (The) reissued a “neutral” rating and set a GBX 1,380 ($18.15) price objective on shares of Smith & Nephew plc in a report on Monday, September 11th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of GBX 1,302.83 ($17.14).

Smith & Nephew plc (LON SN) opened at GBX 1,321 ($17.37) on Monday. Smith & Nephew plc has a 12-month low of GBX 1,064.91 ($14.01) and a 12-month high of GBX 1,442 ($18.97).

ILLEGAL ACTIVITY NOTICE: “J P Morgan Chase & Co Lowers Smith & Nephew plc (SN) Price Target to GBX 1,369” was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://www.watchlistnews.com/j-p-morgan-chase-co-lowers-smith-nephew-plc-sn-price-target-to-gbx-1369/1704184.html.

About Smith & Nephew plc

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Analyst Recommendations for Smith & Nephew plc (LON:SN)

Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with Analyst Ratings Network's FREE daily email newsletter.